# Study of E7389 in Patients With Advanced Solid Tumors

> **NCT00069264** · PHASE1 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 33 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** E7389

## Key facts

- **NCT ID:** NCT00069264
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2005-03
- **Final completion:** 2005-07
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2011-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00069264

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00069264, "Study of E7389 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00069264. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*